Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion

2025-11-17 | original

read original get Medication → more articles

Johnson & Johnson has agreed to buy clinical-stage biotechnology company Halda Therapeutics for $3.05 billion in cash in a deal that bolsters the healthcare giant’s oncology pipeline.

Explore topics: agreed agreed buy billion billion cash biotechnology